StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca established Rest of World (Japan, Canada, Australia & New Zealand) — Total revenue ($M) ($M)

Form 6-K Quarterly & Form 20-F Regional Revenue Table

Latest, FY2025
5,247
Period ended Dec 31, 2025
Change on a year earlier
+5.5%
4,975 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstablished Rest of World (Japan, Canada, Australia & New Zealand) — Total revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20255,247+5.5%Form 6-K FY2025Q4 Earnings Release ↗
FY2024Dec 31, 20244,975-2.4%Form 6-K FY2024Q4 Earnings Release ↗
FY2023Dec 31, 20235,099-14.3%Form 6-K FY2023Q4 Earnings Release ↗
FY2022Dec 31, 20225,948+22.4%Form 6-K FY2022Q4 Earnings Release ↗
FY2021Dec 31, 20214,858+37.5%Form 6-K FY2021Q4 Earnings Release ↗
FY2020Dec 31, 20203,533–Form 6-K FY2020Q4 Earnings Release ↗

Breakdown

What makes up established rest of world (japan, canada, australia & new zealand) — total revenue ($m)

Cite this data

StockData. (2026). AstraZeneca Established Rest of World (Japan, Canada, Australia & New Zealand) — Total revenue ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rev_reg_erow

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.